Colombia vs Liberia: The number of people with susceptibility test result for rifampicin
Colombia
39.17
in 2021
Liberia
37.16
in 2021
Colombia rank
125th
Liberia rank
126th
The number of people with susceptibility test result for rifampicin over time
- Colombia
- Liberia
How they compare
Colombia currently reports 39.17 against 37.16 in Liberia, a difference of 2.01.
That makes Colombia's figure about 1.1 times Liberia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Liberia ahead.
Colombia ranks 125th and Liberia ranks 126th of 146 countries.
Liberia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.03 | 35.42 | 13.38 | Liberia |
| 2020s | 29.98 | 30.78 | 0.7987 | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Colombia or Liberia?
- Colombia, at 39.17 against 37.16 in Liberia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Colombia and Liberia?
- 2.01, with Colombia ahead.
- How many years of comparable data are there for Colombia and Liberia?
- 5 years are reported by both, from 2017 to 2021.
- How do Colombia and Liberia rank globally for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 125th and Liberia ranks 126th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.